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ABSTRACT 
Objective: To support decision making on how to best redesign chronic care by 
studying the heterogeneity in effectiveness across chronic care management 
evaluations for heart failure. 
Data Sources: Reviews and primary studies that evaluated chronic care management 
interventions.  
Study design: A systematic review including meta-regression analyses to investigate 
three potential sources of heterogeneity in effectiveness: study quality, length of 
follow-up, and number of Chronic Care Model (CCM) components.  
Principal findings: Our meta-analysis showed that chronic care management reduces 
mortality by a mean of 18% (95% CI: 0.72-0.94) and hospitalization by a mean of 
18% (95% CI: 0.76-0.93) and improves quality of life by 7.14 points (95% CI: -9.55 - 
-4.72) on the Minnesota Living with Heart Failure questionnaire. We could not 
explain the considerable differences in hospitalization and quality of life across the 
studies.  
Conclusion: Chronic care management significantly reduces mortality. Positive 
effects on hospitalization and quality of life were shown, however, with substantial 
heterogeneity in effectiveness.  This heterogeneity is not explained by study quality, 
length of follow-up, or the number of CCM components. More attention  to the 
development and implementation of chronic care management is needed to support 
informed decision making on how to best redesign chronic care. 
 
Keywords: 
Heart failure, chronic care management, quality improvement, statistical 
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INTRODUCTION 
Heart failure poses significant challenges to health care systems. Health care demands 
as well as health care costs are likely to rise (Lee et al. 2004; Liao, Allen, and 
Whellan 2008),  since the prevalence of heart failure is expected to increase 
substantially due to ageing and increased survival (Cowie et al. 2002; Levy et al. 
2002; Najafi, Jamrozik, and Dobson 2009). Moreover, there is a considerable gap 
between appropriate care for chronic conditions and the care actually received. 
Finally, there is an increasing need for more patient centred care (Bosch et al. 2009; 
Fonarow 2006; McGlynn 2003).  
To address these challenges (Bodenheimer, and Fernandez 2005; IOM 2001), 
various approaches have been proposed to improve the care for patients with heart 
failure. Perhaps best known are the concept of disease management and the chronic 
care model (CCM), while case management, integrated care, and care coordination 
are also often mentioned in relation to chronic care management (Gress et al. 2009). 
The CCM is widely adopted as an evidence-based tool to improve chronic care (Busse 
et al. 2010; Coleman et al. 2009; Wagner et al. 2001).   
Notwithstanding the awareness among policy makers, healthcare professionals 
and patients of the importance of chronic care management, coming to strong 
conclusions regarding the effectiveness of chronic care management interventions has 
been limited. Substantial heterogeneity between study outcomes  - the variation in 
effectiveness between studies is higher than is to be expected by chance alone - limits 
insight into the effectiveness of chronic care management (Clark, Savard, and 
Thompson 2009; Coleman et al. 2009; Mattke, Seid, and Ma 2007). This statistical 
heterogeneity is not only caused by clinical diversity (e.g. differences in interventions, 
like type and number of included CCM components, and outcomes studied), but also 
by methodological diversity (e.g. differences in length of follow-up and study design).  
Insight into heterogeneity in effectiveness is needed to support the 
understanding of and decision making on chronic care management strategies. Some 
reviews tried to address the heterogeneity in outcomes by subgroup analysis (Gonseth 
et al. 2004; Kim, and Soeken 2005; Roccaforte et al. 2005; Taylor et al. 2005). 
However, meta-regression analyses are needed to determine whether the differences 
between subgroups are stronger than is to be expected by chance alone. Although 
meta-regression analysis is a more promising tool to identify the characteristics of 
programs that predict better outcomes (Clark et al., 2009), this has only been 
performed once restricted to randomized clinical trials (Gohler et al. 2006).  
This paper presents an overview of reviews and studies with the aim to provide 
insight into the currently available evidence of chronic care management 
interventions, taking the clinical and methodological variation into account.  In 
addition, meta-regression analyses were performed to gain insight in three potential 
causes of heterogeneity. It was hypothesized that differences in outcomes between the 
studies could be explained by differences in the following factors: 1) methodological 
quality of the studies; 2) length of follow-up; and, 3) number of CCM components 
addressed by the interventions. This paper aims to support the understanding of and 
decision making on chronic care management strategies for heart failure by reporting 
on the effect and their factors explaining the heterogeneity in effectiveness between 
chronic care management interventions.  
 METHODS 
Literature search 
Electronic database searches for English language systematic reviews and meta-
analyses published between 1995 and 2009 were conducted in Medline and CINAHL, 
using the following Medical Subject Headings (MeSH): patient care team, patient 
care planning, primary nursing care, case management, critical pathways, primary 
healthcare, continuity of patient care, guidelines, practice guideline, disease 
management, comprehensive healthcare, and ambulatory care. These were combined 
with the MeSH term heart failure. In addition, disease state management, disease 
management, integrated care, coordinated care, and shared care in combination with 
heart failure were searched as text words in title and/or abstract words.  
 
Study inclusion and data extraction 
Systematic reviews and primary papers were included if they focused on:  1) heart 
failure as the main condition of interest; 2) adult patients as the main receivers of the 
interventions; and 3) interventions addressing at least two CCM components (Wagner 
et al. 2001). Studies published before 1995 were excluded; around that year chronic 
care management strategies became an important issue (Norris et al. 2003). Case 
reports and expert opinions were also excluded. Two reviewers (HD and LS) 
independently extracted data, using separate data entry forms for systematic reviews 
and primary papers. Disagreements were resolved by consensus with the third author 
(LL).                                                                           
 
Assessing the sources of heterogeneity 
Substantial heterogeneity in effectiveness across chronic care management 
interventions is likely, i.e. differences in study outcomes are probably greater than is 
to be expected by chance alone (Clark et al. 2009; Coleman et al. 2009). We identified 
three factors which may explain the heterogeneity in effectiveness: study quality, 
length of follow-up, and the number of CCM components.  
First, study quality is expected to explain part of the heterogeneity in 
outcomes, but this has not yet been tested by means of meta-regression analyses 
(Gonseth et al. 2004; Kim, and Soeken 2005; Roccaforte et al. 2005; Taylor et al. 
2005). We used the validated HTA-DM instrument to classify the primary studies as 
demonstrating either low (<50 points), moderate (50 to 69 points), or high quality (70 
to 100 points) (Steuten et al. 2004).  The HTA-DM instrument  reliably measures the 
methodological quality of health technology assessments of disease management 
(Steuten et al. 2004). We used this instrument to determine to what extent study 
quality explains the heterogeneity in results between studies.  
Second, length of follow-up was assessed as chronic care management 
interventions require behavioural, organisational and cultural changes which tend to 
take considerable time to take effect (Grol et al. 2007). Length of follow-up equals the 
reported number of months of the follow-up period.   
Third, the number of CCM components was taken into account as more 
comprehensive programs were expected to be more effective (Wagner et al. 2005). 
The number of CCM components addressed by the chronic care management 
interventions was identified following the coding scheme of Zwar et al.: self 
management support (SMS) (i.e. supporting patients to manage their condition by 
routinely assessing progress, education, etc); delivery system design  (DSD) (i.e. the 
organization of providing care such as planned visits, other roles/teams, etc.); decision 
support (DS) (i.e. integration of evidence based clinical guidelines into practice by 
reminder system, feedback system, etc); and clinical information systems (CIS) (i.e. 
information systems to capture and use critical information like reminders, feedback 
on performance, etc.) (Zwar et al. 2006). 
 
Data analyses 
Data collected from reviews were descriptively analyzed and data gathered from 
primary studies were descriptively analyzed and meta-analyzed. The outcomes 
measured most frequently, i.e. hospitalization rate, mortality, and quality of life, were 
meta-analyzed.  Review Manager (RevMan 5.0.2) was used to compute the pooled 
overall effects and the pooled effects for the subgroups of the three factors i.e. quality 
of study (poor, moderate, or good), length of follow-up (less than one year or longer), 
and number of components (two, three, or four). Pooled risk ratios for dichotomous 
outcomes were analyzed with the Mantel-Haenszel method using the random effect 
model (Lipsey, and Wilson 2001). Pooled mean differences for continuous outcomes 
were analyzed with the random model of Dersimonian and Laird (Lipsey, and Wilson 
2001).  
Meta-regression analysis was performed to determine to what extent the 
heterogeneity is explained by the quality of the studies, the length of follow-up, and 
the number of CCM components, if at least ten studies could be included in the 
analyses (The Cochrane Collaboration 2009). In contrast with the subgroup analyses, 
all factors were taken into account as continuous variables. The effect sizes of primary 
studies were weighted using the inverse variance weight formulas (Lipsey, and 
Wilson 2001) and imported together with the co-variates into the SAS statistical 
package (version 9.2) (van Houwelingen, Arends, and Stijnen 2002). The extent to 
which the three factors explained the variance between studies was examined by 
fitting of univariable meta-regression models (Thompson, and Higgins 2002). The 
relative decrease of the between-study variance in the univariable model compared to 
an intercept only model was interpreted as the percentage of heterogeneity explained.  
 
[FIGURE 1] 
 
RESULTS 
Results of the search 
Fifteen systematic reviews and 46 primary studies (reported in 47 papers) were 
included (Figure 1). A description of the included reviews is available online as are all 
the references of these papers (Appendix 1). The number of primary papers included 
in the reviews varied from 6 to 54. The included set of primary papers consists of 32 
randomized controlled trials, 4 non-randomized controlled clinical trials, 9 before-
after studies, and 1 chart review.  
 
Findings from the systematic reviews 
The definitions of chronic care management as well as the nature of the included 
interventions varied. Some interventions were purely physician driven, other were 
nurse-led; some were clinic-based, other involved home care, etc. (Appendix 1).  A 
common aspect of the included interventions was a strong focus on reducing hospital 
admissions, and hence on (post)discharge planning and self-management. The 
reported outcome measures varied. Almost all reviews reported hospitalization, 
whereas other outcomes, like patient satisfaction and quality of life, were measured by 
less than half of the reviews. 
Overall, the reviews showed positive effects, although with substantial 
heterogeneity between study outcomes. Most meta-analyses revealed a significant 
reduction on all-cause hospitalization (Gohler et al. 2006; Gonseth et al. 2004; 
Gwadry-Sridhar et al. 2004; McAlister et al. 2001; Phillips et al. 2004; Roccaforte et 
al. 2005; Taylor et al. 2005) with a relative risk reduction ranging from 12 to 25 per 
cent. Results on mortality were less convincing; only two reviews reported a 
significant positive effect (Gohler et al. 2006; Roccaforte et al. 2005). Results on 
quality of life were inconclusive, as it was less frequently used as an outcome measure 
and only once meta-analyzed (Appendix 1).  
Several meta-analyses included subgroup analyses to determine whether 
specific variables, like age or length of follow-up, were associated with the 
effectiveness of chronic care management interventions. To find out whether the 
differences between subgroups were stronger than was to be expected by chance 
alone, a meta-regression analysis should be performed. However, we found only one 
study that included a meta-regression analysis (Gohler et al. 2006).  Since Gohler et 
al. limited this meta-regression analysis to RCT’s, insight into the effect of the three 
selected factors, i.e. study quality, length of follow-up, and number of components, is 
limited.  
 
Findings from the primary studies 
Of the 46 included primary studies, 44% scored ‘good’ on methodological quality 
(Ansari et al. 2003; Atienza et al. 2004; Austin et al. 2005; Blue et al. 2001; Bouvy et 
al. 2003; Capomolla et al. 2002; DeBusk et al. 2004; Doughty et al. 2002; Ducharme 
et al. 2005; Dunagan et al. 2005; Ekman et al. 1998; Gattis et al. 1999; GESICA 2005; 
Harrison et al. 2002; Krumholz et al. 2002; Riegel et al. 2002; Stewart, and Horowitz 
2002; Stewart, Marley, and Horowitz 1999; Stewart, Pearson, and Horowitz 1998; 
Stromberg et al. 2003), 41% scored ‘moderate’ (Benatar et al. 2003; Bull, Hansen, 
and Gross 2000; Cline et al. 1998; Costantini et al. 2001; Heidenreich, Ruggerio, and 
Massie 1999; Hughes et al. 2000; Kasper et al. 2002; Laramee et al. 2003; McDonald 
et al. 2002; Naylor et al. 2004; Oddone et al. 1999; Pugh et al. 2001; Rich et al. 1995; 
Weinberger, Oddone, and Henderson 1996), and 15% scored ‘poor’ (Akosah et al. 
2002; Azevedo et al. 2002; Branch 1999; Rainville 1999; Rauh et al. 1999; Roglieri et 
al. 1997; Tsuyuki et al. 2004). Length of follow-up varied between three to 50 
months; two studies reported more than one year (GESICA 2005; Stewart, and 
Horowitz 2002). The numbers of studies addressing four, three, or two CCM 
components were eighteen, seventeen, and eleven studies, respectively. The 
component of chronic care management included most frequently was SMS (n=43), 
followed by DSD (n=38), CIS (n=37), and DS (n=27) (Table 1).  
 
[TABLE 1] 
 
Notwithstanding the differences in the operationalisation of the CCM 
components between studies, some general trends could be identified. SMS often 
consisted of patient education and telephone follow-up, DSD was often realized by 
the introduction of a specialized nurse and/or multidisciplinary team, CIS mainly 
consisted of telephone follow-up and DS of protocols for chronic care management. 
Most studies were performed in primary and secondary care settings with about half 
of the studies starting after hospitalization. The study aims varied between improving 
medication prescription (e.g. appropriate beta-blocker prescription), medication 
adherence (e.g. beta-blocker use), and self-management (e.g. by providing education, 
self-management monitoring tools, exercise or diet advice), usually with a strong 
focus on reducing hospitalization.  
 
Hospitalization 
The measures of all-cause and HF hospital admission varied between the studies (e.g. 
at least one hospitalization, length of stay, and cumulative hospital days). The relative 
risk of at least one hospitalization for any cause was measured most frequently (n=27) 
(Atienza et al. 2004; Austin et al. 2005; Blue et al. 2001; Capomolla et al. 2002; Cline 
et al. 1998; DeBusk et al. 2004; Doughty et al. 2002; Ducharme et al. 2005; Dunagan 
et al. 2005; Ekman et al. 1998; Fonarow et al. 1997; GESICA 2005; Harrison et al. 
2002; Hughes et al. 2000; Krumholz et al. 2002; Laramee et al. 2003; Naylor et al. 
2004; Oddone et al. 1999; Pugh et al. 2001; Rich et al. 1995; Riegel et al. 2002; Shah 
et al. 1998; Stewart, and Horowitz 2002; Stewart et al. 1999; Stewart et al. 1998; 
Stromberg et al. 2003; Tsuyuki et al. 2004). The result of five studies were not 
included in the meta-analysis because of missing data (Krumholz et al. 2002; Shah et 
al. 1998; Stromberg et al. 2003) or because preliminary results were reported (we only 
included the last results of the same primary study) (Stewart et al. 1999; Stewart et al. 
1998). In total, 22 studies were included in our meta-analysis on all-cause 
hospitalization (i.e. the number of patients with at least one all-cause hospitalization 
during the study period). 
The pooled relative risk for all-cause hospitalization with chronic care 
management compared to the control intervention (mostly usual care) is 0.82 (95%-
CI: 0.72-0.94; I
2
:84%). Subgroup analyses showed that studies of good 
methodological quality, with a follow-up period of at least one year, and studies 
reporting on interventions including three CCM components demonstrated a 
significant reduction in the number of patients with at least one all-cause 
hospitalization. The associations suggested by the subgroup analyses, like the positive 
association between the study quality and hospitalization, were tested by the meta-
regression analysis.  Meta-regressions showed no significance of the three factors 
(p>0.50), which implies that these could not significantly explain the heterogeneity 
between the studies.  
 
[TABLE 2] 
 
Mortality  
Twenty-nine studies reporting on all-cause mortality were included in our meta-
analysis (Akosah et al. 2002; Ansari et al. 2003; Atienza et al. 2004; Austin et al. 
2005; Azevedo et al. 2002; Blue et al. 2001; Bouvy et al. 2003; Capomolla et al. 
2002; Cline et al. 1998; DeBusk et al. 2004; Doughty et al. 2002; Ducharme et al. 
2005; Dunagan et al. 2005; Ekman et al. 1998; Gattis et al. 1999; GESICA 2005; 
Kasper et al. 2002; Krumholz et al. 2002; Laramee et al. 2003; McDonald et al. 2002; 
Naylor et al. 2004; Oddone et al. 1999; Pugh et al. 2001; Rainville 1999; Rich et al. 
1995; Stewart, and Horowitz 2002). Overall, the pooled effect showed a significantly 
reduced relative risk of mortality (RR: 0.82; 95%-CI: 0.76-0.93; I
2
=0%). This implies 
that the chance to die during the follow-up period is reduced by 18% for patients 
receiving chronic care management.  
Subgroup analyses showed that pooled effects for studies of a moderate 
quality, with a follow-up period of less than one year, or on three CCM components 
were not associated with a significant reduction of mortality (Table 2). Meta-
regression analysis was used to determine whether the variables were associated with 
the effect, as no heterogeneity had to be explained (I
2
=0%).  The meta-regression 
analysis showed that none of the variables were associated with the effect of chronic 
care management on mortality (p>0.05).  
 
Quality of life 
A variety of instruments was used to assess quality of life; the Minnesota Living with 
Heart Failure (MLHF) questionnaire was used most frequently (n=14) (Atienza et al. 
2004; Austin et al. 2005; Benatar et al. 2003; Bouvy et al. 2003; Doughty et al. 2002; 
Ducharme et al. 2005; Dunagan et al. 2005; GESICA 2005; Harrison et al. 2002; 
Holst et al. 2001; Kasper et al. 2002; Naylor et al. 2004; Stewart et al. 1999; 
Vavouranakis et al. 2003).  The scores of the MLHF questionnaire range from 0 (best 
quality of life score) to 105 (worst quality of life score). For the meta-analysis, results 
of seven studies could be used (Austin et al. 2005; Benatar et al. 2003; Bouvy et al. 
2003; Harrison et al. 2002; Holst et al. 2001; Naylor et al. 2004; Vavouranakis et al. 
2003), the remaining studies were excluded because of missing or skewed data. 
(Atienza et al. 2004; Doughty et al. 2002; Ducharme et al. 2005; Dunagan et al. 2005; 
GESICA 2005; Kasper et al. 2002; Stewart et al. 1999).  
The meta-analysis demonstrated a significant improvement in quality of life of 
7.14 points on the MLHF questionnaire (95% CI: -9.55- -4.72). Subgroup analyses 
showed that the pooled effect of studies of a good quality, with a follow-up of less 
than one year, or on two or three components are significantly positive (Table 3). The 
heterogeneity between the studies in the subgroups is substantial (I
2
: 50%-90%) or 
considerable (I
2 
> 75%). Meta-regression analysis could not be performed, as less than 
ten studies were available.  
 
DISCUSSION 
This systematic review showed that predominantly positive effects of chronic care 
management on clinical outcomes and health care consumption were reported by 
earlier reviews. Since size and significance of the effects vary due to considerable 
methodological and clinical heterogeneity between the reviews and their included 
studies, we performed a meta-regression analysis. The analysis showed a significant 
reduction of 18% in mortality, irrespective of the differences between the studies. 
Furthermore, all-cause hospitalization and quality of life improved significantly, yet, 
with substantial heterogeneity between the studies which could not be explained by 
the quality of the studies, the length of follow-up, or the number of CCM components.  
In addition to previously published reviews and studies, this review gives a 
comprehensive overview of previously published reviews and studies as well as a 
meta-regression analysis to explain the heterogeneity in outcomes. Although several 
reviews showed substantial differences in effect of chronic care management in 
subgroup meta-analyses for the quality of the studies, the direction of these 
differences was inconsistent between these reviews (Gonseth et al. 2004; Kim, and 
Soeken 2005; Roccaforte et al. 2005; Taylor et al. 2005). None of these reviews had 
tested these associations suggested by the subgroup analysis with meta-regression 
analysis. Length of follow-up was studied in one meta-regression study only. In line 
with our results, Gohler et al. concluded that the effect on hospitalization remained 
when follow-up exceeded 3 months (Gohler et al. 2006). In addition, these authors 
reported substantial effects on mortality due to diversity in length of follow-up, but 
significance of this explained heterogeneity was not reported (I
2
=34). 
Our study aimed to find out whether the number of CCM components is 
positively associated with the effect of chronic care management, as comprehensive 
programs are expected to be more effective (Wagner et al. 2005). We found no 
association between the number of components and the effect of chronic care 
management. However, other aspects of chronic care management interventions such 
as the integration of the components could also influence its effectiveness. Only one 
earlier review tried to explain heterogeneity by characteristics of chronic care 
management using meta-regression analysis. Gohler et al. found that the number of 
disciplines participating in the chronic care management interventions explained 60% 
and 68% of the differences in effect size for mortality and hospitalization, respectively 
(Gohler et al. 2006). These results are in line with several subgroup analyses 
previously published (Duffy, Hoskins, and Chen 2004; McAlister et al. 2001; 
Sochalski et al. 2009) and imply that chronic care management is more effective if 
more disciplines participate. Subgroup analysis identified several other characteristics 
that might  influence the effectiveness of chronic care management interventions:  in-
person communication (Sochalski et al. 2009), follow-up at the out-patient clinic 
(Whellan et al. 2005), complex programs that include hospital discharge planning and 
no delay in post-discharge clinic follow-up (Phillips et al. 2005), patient education 
(McAlister et al. 2001; Windham, Bennett, and Gottlieb 2003; Yu, Thompson, and 
Lee 2006), and ongoing patient monitoring (Ansari et al. 2003; Yu et al. 2006). 
However, the influence of these characteristics must be interpreted with caution, as 
the reported associations were not tested by meta-regression analyses.     
Several limitations should be noted. First, even though an extensive search, 
based on the WHO’s broad definition of chronic care management, was performed, 
we restricted the selection of our primary studies to published reviews. As a 
consequence, publication bias might have influenced the results, since more negative 
results and/or recently published studies were not included. However, this limitation 
will probably be limited, as the reviews included were peer reviewed and most of 
them included a publication bias analysis. Next, it is disputable whether the HTA-DM 
instrument - the only tested instrument for assessing the quality of complex 
interventions - properly measures the items that bias the effect of the interventions for 
heart failure, as it primarily focuses on the quality of reporting. Thirdly, we limited 
our analysis to three a-priori selected variables, that is the quality of the studies, the 
length of follow-up, and the number of CCM components. However, additional 
causes of heterogeneity are suggested and should be further studied. For instance, it 
was suggested that more recent studies showed a lower or no effectiveness of chronic 
care management interventions compared to earlier studies (Clark, and Thompson 
2010). Although additional analyses of our data set showed that year of study 
performance did not explain heterogeneity (data not shown), more recent studies 
should be included in future reviews since we only included studies from before 2006. 
Besides year of study performance, other causes of heterogeneity should be studied 
such as contextual factors (e.g. professional’s behaviour and unit of randomization) as 
well as characteristics of the intervention (e.g. combination of CCM components and 
intervention intensity). For example, almost all studies randomized on patient level 
except four studies, with contamination as well as limited insight in the contextual 
influences as a consequence. Furthermore, results of our subgroup analysis should be 
interpreted with caution, since these results are more than once based on less than 10 
studies. Meta-regression analysis gave the opportunity to restrict this limitation for the 
length of follow-up and the study quality by including these variables as continuous 
variables. Finally, analyses of heterogeneity are limited by the quality and 
comprehensiveness of data reported in the primary studies. In particular, the care 
received by the control group, as well as results, such as p-values and standard 
deviations, were frequently not fully reported, and were therefore excluded from our 
meta-analysis.  
As insight into the effect of chronic care management for heart failure is 
limited, more efforts should be made to assess the effectiveness. In particular, the 
follow-up period of chronic care management should be extended to enable the 
assessment of the effects after several years. Complex improvements, which need 
behavioral, organizational, and cultural changes, need time to take effect. Only 
Stewart and colleagues had a follow-up period of more than 2 years, but the 
intervention in this study consisted of just one home visit (Stewart, and Horowitz 
2002). Furthermore, the influence of co-morbidity, which is highly prevalent in the 
heart failure population, (Bayliss, Ellis, and Steiner 2007; Marengoni et al. 2009) 
needs to be addressed, which the earlier primary studies failed to do. Moreover, 
effectiveness is most frequently assessed using clinical outcomes, like mortality and 
hospitalization, whereas more patient-centered outcomes are less frequently 
monitored. Meanwhile, a great variety of instruments that are sometimes difficult to 
compare is used to measure outcomes, like patient satisfaction and medication 
adherence, which complicates comparing or pooling of data.   
Consequently, insight into the influence of other factors of chronic care 
management than those three studied in our review (study quality, length of follow-
up, and number of CCM components)  is needed.  Although these three variables for 
the subgroup analyses and meta-regression were selected on the basis of available 
evidence (McAlister et al. 2001; Windham et al. 2003; Yu et al. 2006), heterogeneity 
between studies regarding the effect on quality of life and hospitalization might be 
caused by variables other than those measured, such as the extent to which the 
components are implemented and the contextual setting (Berwick 2008; Clark, and 
Thompson 2010), which highlights the need for multilevel analysis. Even though 
context and manner of implementation are expected to influence the effectiveness of 
chronic care management, as implementing such complex interventions is essentially 
a process of social change (Berwick 2008; Clark, and Thompson 2010; Lemmens et 
al. 2008), studies revealed little about these influences. For instance, professional 
behavior is likely to influence the effectiveness of chronic care management 
interventions (Clark, and Thompson 2010). More attention should be paid to proper 
development and implementation of chronic care management programs to use its full 
potential to create a comprehensive care for chronically ill.  
 
Conclusion 
Our meta-regression analysis showed that mortality is reduced by chronic care 
management, irrespective of the differences between the studies included. 
Furthermore, the meta-regression analysis revealed that all-cause hospitalization and 
the quality of life could significantly be improved by chronic care management. The 
study quality, the length of follow-up, and the number of CCM components do not 
determine the effectiveness of chronic care management. Considering the unexplained 
heterogeneity in effectiveness across chronic care management interventions, more 
attention  to the development and implementation of chronic care management is 
needed to support informed decision making about how to best redesign chronic care. 
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 Figure 1: Study in/exclusion flowchart  
 
 
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
    
 
 
 
 
 
Reviews excluded: n=126 
Reasons (reviews may be excluded for more than one reason): 
1) Focus on single-component interventions: n=108 
2) No systematic review or meta-analysis: n=103 
3) Main focus on other condition than HF: n=46 
4) Main focus on other than adult population: n=41 
 
Potentially relevant reviews identified and 
title/abstract screened for retrieval: n=147 
Reviews retrieved for full text evaluation: n=21 
Primary papers retrieved for full text evaluation: n=54 
Primary papers excluded: n=7 
Reasons: 
1) Single component intervention: n=5 
2) No relevant effectiveness measure reported: n=1 
3) Full text not in English: n=1 
 
 
Primary studies included in the analysis: n=46 
Reviews excluded: n=6 
Reasons: 
1) No systematic review or meta-analysis: n=3 
2) Focus on single-component interventions: n=2 
3) No relevant effectiveness measure reported: n=1 
 
Systematic reviews included in the analysis: n=15 
Primary papers identified from included reviews and 
title/abstract screened for retrieval: n=107 
Primary papers excluded: n=53 
Reasons  (primary papers may be excluded for more than one reason):  
1) Single-component intervention: n=12 
2) Main focus on other condition than HF: n=6 
3) No full text available: n=34 
4) Publication before 1995: n=9 
5) Other: n=2 
Table 1: Overview of primary studies 
 
Author, year of 
publication 
Population†             Intervention Control  Components 
(DSD, SMS, 
DS, CIS)†† 
FU 
(months) 
Quality 
(study 
design)††† 
Akosah et al., 2002 N: 38/ 63; Age: 68 
(16)/ 76 (11)*; Male: 
71/43*; NYHA: NR; 
Country: USA 
Short-term, multidisciplinary, 
aggressive-intervention in HF 
clinic following hospital 
discharge primarily focused on 
patient education and 
medication titration.  
Primary care physician follow-up 
after hospital discharge. 
DSD, SMS 12 40 (Other) 
Ansari et al., 2003 N: 54/ 51; Age: 69 
(11)/ 70 (11); Male: 
94/98; NYHA: NR; 
Country: USA 
Nurse practitioners initiate and 
titrate beta-blockers supervised 
by 2 cardiologists at a single 
academically affiliated 
Veterans Affairs medical centre. 
Provider education on beta-
blockers. 
DSD, DS 12 80 (RCT) 
Atienza et al., 2004 N: 164/ 174; Age: 69 
(IQR 61-74)/ 67 (IQR 
58-74); Male: Total: 
60; NYHA: 2.49/2.5; 
Country: Spain 
Comprehensive hospital 
discharge planning, a visit by 
the primary care physician after 
discharge to monitor and 
reinforce the educational 
knowledge, telemonitoring and 
close follow-up at a HF-clinic. 
Discharge planning according to 
the routine protocol of the 
hospital and follow-up from a 
primary care physician/ 
cardiologist not participating in 
the study. 
DSD, SMS, CIS 12 80 (RCT) 
Austin et al., 2005 N: 100/ 100; Age: 
71.9 (6.3)/ 71.8 (6.8); 
Male: 67/64; NYHA: 
2.44/2.53; Country: 
UK 
Cardiac rehabilitation program 
including patient education, 
exercise training and lifestyle 
modifications, and 8-weekly 
clinic attendance with 
cardiologist and nurse.  
8-Weekly clinic attendance with 
cardiologist and nurse. 
DSD, SMS, DS 5.5 70 (RCT) 
Author, year of 
publication 
Population†             Intervention Control  Components 
(DSD, SMS, 
DS, CIS)†† 
FU 
(months) 
Quality 
(study 
design)††† 
Azevedo et al., 2002 N: 157/ 182; Age: 
69.3 (9.6) /65.0(13.3); 
Male: 52.2; NYHA: 
NR/NR; Country: 
Portugal 
Outpatient management at HF 
clinic by a multidisciplinary 
team after hospital discharge 
based on current RCT's and 
tailored to individual's patient 
characteristics.  
Usual post-discharge 
management, usually by primary 
care physician. 
DSD, DS 12 40 (CCT) 
Benatar et al., 2003 N: 108/ 108; Age: 
62.9(13.2)/63.2 
(12.6); Male: 36/38; 
NYHA: Total:3.12; 
Country: USA 
Nurse telemanagement model 
provided during a period of 3 
months after hospital discharge, 
incorporating an advanced 
practice nurse supervised by a 
cardiologist and home 
monitoring devices to measure 
and transfer physiological signs. 
Home nurse visits model, based 
on clinical pathways and 
guidelines, employing 
specialized cardiac nurses who 
provide regular home visits to 
assess signs and symptoms and 
give education. 
DSD, SMS, CIS 12 65 (RCT) 
Blue et al., 2001 N: 84/ 81; Age: 
75.6(7.9)/74.4(8.6); 
Male: 64/51; NYHA: 
3.2/3.18; Country: 
Scotland 
Nurse specialist making a 
number of planned home visits 
of decreasing frequency, 
supplemented by telephone 
contact as needed, to educate, 
monitor, teach self monitoring 
and management, liaise with 
other health care and social 
workers, and provide 
psychological support.  
Patients in UC were managed by 
the admitting specialist and 
subsequently their GP. They 
were not seen by the specialist 
nurses after hospital discharge.  
DSD, SMS, DS, 
CIS 
12 75 (RCT) 
Bouvy et al., 2003 N: 74/ 78; Age: 
69.1(10.2)/70.2(11.2) 
; Male: 72/60; 
NYHA: 2.54/2.31; 
Country: The 
Netherlands 
Monthly consultations provided 
by trained pharmacist, including 
an initial interview regarding 
patients' drug use and 
subsequent follow-up for 6 
months with computerized 
medication history, to improve 
diuretic compliance.  
Usual care excluding pharmacist 
interview and follow-up. 
DSD, SMS, DS, 
CIS 
6 75 (RCT) 
Author, year of 
publication 
Population†             Intervention Control  Components 
(DSD, SMS, 
DS, CIS)†† 
FU 
(months) 
Quality 
(study 
design)††† 
Branch et al., 1999 N: 23/ 23; Age: Total: 
66(range 36-87); 
Male: Total:52; 
NYHA: NR; Country: 
USA 
CHF clinic that aims to 
maximise outpatient 
management by employing a 
multidisciplinary team of care 
providers and intensive patient 
and familiy 
education,communication and 
involvement. 
Not described. DSD, SMS, DS 3 20 (BA) 
Bull et al., 2000 N: 40/ 71; Age: Total: 
73.7 (8.8); Male: Not 
stated; NYHA: NR; 
Country: USA 
A professional-patient 
partnership model of discharge 
planning, including provider 
education, patient needs 
assessment and information for 
patient and carers given by the 
nurses and social workers at the 
hospital.  
Not described. SMS, CIS 2 50 (CCT) 
Capomolla et al., 2002 N: 112/ 122; Age: 
56(9)/56 (8); Male: 
84/84; NYHA: I-II 
(%): 66/65; Country: 
Italy 
Day hospital follow-up care 
within a HF Unit, which 
implemented an individualized 
HF management program by a 
multidisciplinary team, 
including education,  
Community follow-up care 
provided by a primary care 
physician and supported by a 
cardiologist. 
DSD, SMS, DS, 
CIS 
12 70 (RCT) 
Cline et al., 1998 N: 80/ 110; Age: 
Total: 75.6 (5.3); 
Male: Total:53; 
NYHA: 2.6/2.6; 
Country: Sweden 
Education on HF and self-
management, with follow-up at 
an easy access nurse directed 
outpatient clinic for 1 year after 
discharge. The nurses received a 
lecture and could consults the 
cardiologist.  
Follow-up at the outpatient clinic 
at the department of cardiology, 
by either a cardiologist in private 
practice or a primary care 
physician. 
DSD, SMS, DS 12 60 (RCT) 
Author, year of 
publication 
Population†             Intervention Control  Components 
(DSD, SMS, 
DS, CIS)†† 
FU 
(months) 
Quality 
(study 
design)††† 
Constantini et al., 2001 N: 283/ 173; Age: 
71.8/69.3; Male: 
43/41; NYHA: NR; 
Country: USA 
A cardiologist and nurse care 
manager at an academic medical 
centre reviewed patient's data 
and made guideline-based 
recommendations regarding 
ACE inhibitor; ECG and 
implementation of daily weights 
used for the care manager sheet.  
The nurse provided patient 
education, assessed discharge 
needs, and evaluated patient’s 
ability to comply with 
prescribed plan. 
Care path for CHF that included 
comprehensive and specific 
recommendations for patient care 
on each hospital day. 
DSD, SMS, DS, 
CIS 
NR 50 (CCT) 
DeBusk et al., 2004 N: 228/ 234; Age: 
Total: 72 (11) ; Male: 
48/54; NYHA: NR; 
Country: USA 
Nurse case management 
provided education, structured 
telephone surveillance and 
treatment for heart failure given 
by 5 HMO's hospitals. 
Coordination of patients' care 
with primary care physicians 
according the study protocol. 
Control patients received usual 
care including instruction on diet, 
drug adherence, physical activity, 
and response to changing 
symptoms.  
DSD, SMS, DS, 
CIS 
12 80 (RCT) 
Doughty et al., 2002 N: 100/ 97; Age: 
72.5(11.6)/ 73.5(10); 
Male: 64/57; NYHA: 
3.76/3.75; Country: 
New Zealand 
Integrated primary/secondary 
care involving a clinical review 
at a hospital-based HF clinic 
early after discharge, education 
sessions, a personal diary to 
record medication and body 
weight, information booklets 
and regular (12 month) clinical 
follow-up alternating between 
GP and HF-clinic. 
Care provided by GP with 
additional follow-up measures as 
usually recommended by the 
medical team responsible for the 
in-patient care. 
DSD, SMS, DS, 
CIS 
12 80 (RCT) 
Author, year of 
publication 
Population†             Intervention Control  Components 
(DSD, SMS, 
DS, CIS)†† 
FU 
(months) 
Quality 
(study 
design)††† 
Ducharme et al., 2005 N: 115/ 115; Age: 
68(10)/70(10); Male: 
73/71; NYHA: 
3.27/3.21; Country: 
Canada 
A structured multidisciplinary 
outpatient clinic environment  
with complete access to 
cardiologists and allied health 
professionals, patient education 
and telephone follow-up. 
Treatment and appropriate 
follow-up according to the 
standards of the attending 
physicians. 
DSD, SMS, CIS 6 80 (RCT) 
Dunagan et al., 2005 N: 76/ 75; Age: 
70.5(12.7)/69.4 
(13.9); Male: 41/47; 
NYHA: 2.85/2.94; 
Country: USA 
Scheduled telephone calls by 
specially trained nurses working 
at the hospital promoting self-
management and guideline-
based therapy as prescribed by 
primary physicians, additional 
to an educational booklet that is 
part of usual primary care. 
Usual care from primary 
physician including an 
educational packet describing the 
causes of HF, the basic principles 
of treatment, their role in routine 
care and monitoring and 
appropriate strategies for 
management a HF exacerbation. 
SMS, DS, CIS 12 80 (RCT) 
Ekman et al., 1998 N: 79/ 79; Age: Total: 
80.3 (6.8); Male: 
58/63; NYHA: 
3.2/3.2; Country: 
Sweden 
A nurse monitored, outpatient 
care programme aiming at 
symptom management, 
including education, 
cooperation of nurses and 
doctors, telephone follow-up 
stated in practical guidelines.  
Management in accordance with 
current clinical practice, meaning 
GP follow up and ED-encounter 
in case of worsening symptoms. 
DSD, SMS, DS, 
CIS 
6 70 (RCT) 
Fonarrow et al., 1997 N: / ; Age: Total: 52 
(10); Male: Total: 81; 
NYHA: NR; Country: 
USA 
Comprehensive HF 
management programme, 
including guideline based 
medication management, nurse 
provided individual and group 
education and cardiologist 
follow-up care and telephone 
follow-up after discharge. 
Not described. SMS, DS, CIS 6 50 (BA) 
Author, year of 
publication 
Population†             Intervention Control  Components 
(DSD, SMS, 
DS, CIS)†† 
FU 
(months) 
Quality 
(study 
design)††† 
Gattis et al., 1999 N: 90/ 91; Age: 71.5 
/63*; Male: 69/67; 
NYHA: NR; Country: 
USA 
Clinical pharmacist evaluation, 
which included medication 
evaluation, therapeutic 
recommendations to the 
attending physician, patient 
education and follow-up 
monitoring. 
Patient assessment and education 
by the attending physician and/or 
physician assistant/ nurse 
practitioner and telephone 
follow-up by the pharmacist at 12 
& 124 weeks to identify clinical 
events. 
DSD, SMS, DS, 
CIS 
6 70 (RCT) 
GESICA, 2005 N: 760/ 758; Age: 
64.8(13.9)/65.2(12.7); 
Male: 73/69 ; NYHA: 
NR; Country: 
Argentina 
Frequent telephone follow-up 
from a single surveillance centre 
provided by nurses trained in 
HF to monitor and reinforce self 
management performed by 
using a predetermined 
questionnaire. 
Treatment by the attending 
cardiologist according to the 
usual care practice; patients were 
not contacted by the surveillance 
centre. 
DSD, SMS, DS, 
CIS 
16 85 (RCT) 
Harrison et al., 2002 N: 92/ 100; Age: 
76(9.4)/76(10.4); 
Male: 53/56; NYHA: 
2.89/2.84; Country: 
Canada 
The Transitional Care used a 
comprehensive evidence-based 
protocol for counselling and 
education for HF self-
management plus additional and 
planned linkages to support 
individuals in taking charge  of 
aspects of their care given by 
hospital and community nurses. 
Usual care for hospital to home 
transfer involves completion of 
medical history, nursing 
assessment form and in ideal 
circumstances within 24-hours of 
hospital admission a 
multidisciplinary discharge plan. 
DSD, SMS, DS, 
CIS 
2.8 70 (RCT) 
Heidenreich et al., 
1999 
N: 68/ 86; Age: 
74(13)/75(11); Male: 
58/58; NYHA: NR; 
Country: USA 
Multidisciplinary program of 
patient education, daily self-
monitoring, and physician 
notification of abnormal weight 
gain, vital signs and symptoms 
given by small practices (largely 
primary care) of a 
multispeciality group.  
Not described. SMS, CIS 12 65 (CCT) 
Author, year of 
publication 
Population†             Intervention Control  Components 
(DSD, SMS, 
DS, CIS)†† 
FU 
(months) 
Quality 
(study 
design)††† 
Holst et al., 2001 N: 36/ 36; Age: Total: 
54(13); Male: Total: 
81; NYHA: NR; 
Country: Australia 
Comprehensive management 
program of cardiology 
assessment, intensive education 
and referral to a tailored 
exercise program. 
Not described. DSD, SMS 6 50 (BA) 
Hughes et al., 2000 N: 981/ 985; Age: 
70.4(10.3)/70.4 
(10.3); Male: 97/96; 
NYHA: NR; Country: 
USA 
Home based primary care, 
including a primary care 
manager, 24-hour contact for 
patients and Home Based 
Primary Care team participation 
in discharge planning. 
Customary Veterans Affairs and 
private sector care. 
DSD, CIS 12 60 (RCT) 
Kasper et al., 2002 N: 102/ 98; Age: 
60.2(13.8)/63.7(15.0); 
Male: 65/56; NYHA: 
2.22/2.46; Country: 
USA 
Multidisciplinary team 
including nurse coordinator 
(monitored by telephone calls); 
CHF nurse (adjusting 
medication in CHF clinic), CHF 
cardiologist (decision support 
for nurses); primary physician 
(received updates and managed 
all not CHF related problems). 
Intervention given during 6 
months.  
Care as usual by their primary 
physicians.  
DSD, SMS, DS, 
CIS 
6 65 (RCT) 
Author, year of 
publication 
Population†             Intervention Control  Components 
(DSD, SMS, 
DS, CIS)†† 
FU 
(months) 
Quality 
(study 
design)††† 
Krumholz et al., 2002 N: 44/ 44; Age: 
75.9(8.7)/71.6(10.3); 
Male: 48/66; NYHA: 
NR; Country: USA 
Face-to-face education session 
followed by a telemonitoring 
phase by the nurse for a total 
intervention period of 1 year. 
This telephone contacts 
reinforced care domains but did 
not modify current regimens or 
recommendations; the patient 
learned to understand when and 
how to seek and access the care. 
Received all usual care 
treatments and services ordered 
by their physicians.  
DSD, SMS 12 70 (RCT) 
Laramee et al., 2003 N: 141/ 146; Age: 
70.6(11.4)/70.8(12.2); 
Male: 48/50; NYHA: 
2.33/2.19; Country: 
USA 
Four major components: early 
discharge planning, patient and 
family CHF education, 12 
weeks of telephone follow-up 
and promotion of optimal CHF 
medications given by a CHF 
case manager of the hospital.  
Standard care, typical of a 
tertiary care hospital, and all 
conventional treatments 
requested by the attending 
physician. Post discharge care 
given by the own local physician.  
DSD, SMS, DS, 
CIS 
3 60 (RCT) 
McDonald et al., 2002 N: 51/ 47; Age: 
70.8(10.4)/70.8(10.7); 
Male: 63/68; NYHA: 
3/3; Country: Ireland 
Specialist nurse-led education 
and specialist dietician consults 
during admission, also given to 
patient's carer. In addition, 
patients were discharged with a 
letter to the referring physician 
about the study and that 
management of HF-related 
issues should be referred to the 
clinic or the nurse. Telephone 
follow-up to ascertain clinical 
status and discuss problems.  
Routine care including ECG and 
right and left heart 
catheterization when indicated. 
Optimal medical therapy was 
administered. Services such as 
dietary and social work 
consultation were provided as 
requested by the attending 
cardiologist.  
DSD, SMS, CIS 3 55 (RCT) 
Author, year of 
publication 
Population†             Intervention Control  Components 
(DSD, SMS, 
DS, CIS)†† 
FU 
(months) 
Quality 
(study 
design)††† 
Naylor et al., 2004 N: 118/ 121; Age: 
76.4(6.9)/75.6(6.5); 
Male: 40/44; NYHA: 
NR; Country: USA 
A 3-months comprehensive 
transitional care intervention 
directed by advanced practice 
nurse (APN) including 
discharge planning and home 
follow-up. APN received a 
training program guided by a 
multidisciplinary team of HF 
experts, implemented an 
evidence-based protocol, 
focused on collaboration 
between caregivers.   
Received care routine for the 
admitting hospital. The attending 
physician was responsible for 
determining the discharge date, 
and the primary nurse, discharge 
planner, and physician 
collaborated in the design and 
implementation of the discharge 
plan. Liaison nurses facilitate 
referrals to home care. 
DSD, SMS, DS, 
CIS 
12 60 (RCT) 
Oddone,  1999 & 
Weinberger et al., 
1996 
N: 249/ 255; Age: 
63.0(11.1)/62.6(10.9); 
Male: Total: 99 (not 
disease specific 
reported); NYHA: 
2.52/2.57; Country: 
USA 
A team consisting of a nurse 
and a primary care physician 
taking care of discharge 
planning, arrangement of visits 
with primary care clinic after 
discharge, telephone follow-up, 
review of treatment plans during 
primary clinic visits consisting 
of an inpatient and outpatient 
component.  
They neither required nor 
prohibited any post-discharge 
care for the patients in the control 
group. Their care after discharge 
could be provided by community 
physicians or at Veterans Affairs 
clinics, as arranged by the 
physicians treating them as 
inpatients. The control patients 
did not have access to the 
primary care nurse and received 
no supplemental education or 
assessment of needs beyond what 
was customarily offered at each 
site. 
DSD, SMS, CIS 6 55 (RCT) 
Pugh et al., 2001 N: 27/ 31; Age: 
70.9(6.8)/77.2(5.9); 
Male: 44/42; NYHA: 
2.64/2.57; Country: 
USA 
Patient education, monitoring 
and providing care by a nurse 
case manager of the clinic 
across the care continuum. 
Followed by their primary care 
physician and a professional 
nurse was assigned to them each 
shift of each day.  
SMS, CIS 6 60 (RCT) 
Author, year of 
publication 
Population†             Intervention Control  Components 
(DSD, SMS, 
DS, CIS)†† 
FU 
(months) 
Quality 
(study 
design)††† 
Rainville et al., 1999 N: 17/ 17; Age: 
72.8910.7)/66.9(8.7); 
Male: 47/53; NYHA: 
2.89/3.17; Country: 
USA 
A pharmacist and clinical nurse 
specialist identified patient 
issues that posed potential risk 
for rehospitalisation, determined 
corrective action, gave patient 
education. 
Patients received routine care and 
preparation for discharge 
consisting of written 
prescriptions, physician 
discharge instructions, and a 
nurse review of diet, treatment 
plans and medications. 
DSD, SMS, CIS 12 45 (RCT) 
Rauh et al., 1999 N: 347/ 407; Age: 
74.4/75.8; Male: 
76/74; NYHA: NR; 
Country: USA 
A multidisciplinary team 
approach, included an intensive 
education program, aggressive 
pharmacologic treatment for 
patients with advanced CHF, 
and telephone follow-up 
following the developed 
treatment protocols.  
Not described. DSD, SMS, DS, 
CIS 
3 45 (BA) 
Rich et al., 1995 N: 142/ 140; Age: 
80.1(5.9)/78.4(6.1); 
Male: 32/41; NYHA: 
2.4/2.4; Country: 
USA 
A nurse-led multidisciplinary 
intervention consisting of 
comprehensive education 
(patient and family), prescribed 
diet, social-service consultation 
and planning for an early 
discharge, a review of 
medications, and after discharge 
intensive follow-up. 
Receive all standard treatments 
and services ordered by their 
primary physicians. 
DSD, SMS, CIS 1.5 60 (RCT) 
Riegel et al., 2002 N: 130/ 228; Age: 
72.5(13.1)/74.6(12); 
Male: 54/46; NYHA: 
NR; Country: USA 
Standardized telephonic case-
management intervention after 
hospital discharge using 
decision-support software based 
on guidelines, and automatically 
produced reports sent to the 
physicians. 
Care was not standardized, and 
no formal telephonic case-
management program existed at 
these institutions. These patients 
presumably received some 
education prior to hospital 
discharge. 
DSD, SMS, DS, 
CIS 
6 75 (RCT) 
Author, year of 
publication 
Population†             Intervention Control  Components 
(DSD, SMS, 
DS, CIS)†† 
FU 
(months) 
Quality 
(study 
design)††† 
Roglieri et al., 1997 N: 149/ 149; Age: 
Missing ; Male: 
Missing ; NYHA: 
NR; Country: USA 
A comprehensive disease 
management program for CHF, 
based on national guidelines, 
including patient education, 
telemonitoring of patients and 
physician education.  
Not described. SMS, DS, CIS 12 25 (BA) 
Shah et al., 1998 N: 27/ 27; Age: Total: 
62 (range 42-81); 
Male: 100/100; 
NYHA: 2.63; 
Country: USA 
Education, self-measurement 
instruments and 24-hours 
telephone access to a nurse to 
report changes in combination 
with telephone contact to 
monitor. Nurses report the 
physician monthly.  
Care as usual (before 
intervention). 
DSD, SMS, CIS 8.5 55 (BA) 
Stewart et al., 1998 N: 49/ 48; Age: 
76(11)/74(10); Male: 
45/52; NYHA: 
2.55/2.42; Country: 
Australia 
Multidisciplinairy home based 
intervention of a single home 
visit (by a nurse and 
pharmacist) to optimize 
medication management, 
identify early deterioration and 
intensify medical follow-up and 
caregiver vigilance as 
appropriate. Additional 
education and incremental 
monitoring by their physician if 
needed.  
Care as usual consisting of a 
review by their primary care 
physician or cardiologist within 2 
weeks of discharge.  
DSD, SMS, CIS 6 70 (RCT) 
Author, year of 
publication 
Population†             Intervention Control  Components 
(DSD, SMS, 
DS, CIS)†† 
FU 
(months) 
Quality 
(study 
design)††† 
Stewart et al., 1999 N: 100/ 100; Age: 
75.2(7.1)/76.1(9.3); 
Male: 65/59; NYHA: 
2.7/2.61; Country: 
Australia 
Multidisciplinary home based 
intervention comprised a single 
home visit (by a cardiac nurse) 
to optimize medication 
management, identify early 
clinical deterioration and 
enhance selfmonitoring.  
All patients (CAU and 
intervention) received 
multidisciplinairy contact with a 
cardiac rehabilitation nurse, 
dietitian, social worker, 
pharmacist, and community 
nurse where appropriate. All 
patients had an appointment with 
primary care physician or 
cardiologist within 2 weeks after 
discharge and all received regular 
outpatient-based review by 
cardiologist during visits.  
DSD, SMS, DS, 
CIS 
6 75 (RCT) 
Stewart et al., 2002 N: 149/ 148; Age: 
75(9)/75(8; Male: 
56/56; NYHA: 
2.61/2.67; Country: 
Australia 
Multidisciplinary home based 
intervention by a cardiac nurse 
and pharmacist to optimize 
medication management, 
identify early clinical 
deterioration and enhance self 
monitoring. Nurses provided a 
critical link to the appropriate 
health care if problems arose.  
Care as usual.  DSD, SMS, CIS 50.4 70 (RCT) 
Stromberg et al., 2003 N: 52/ 54; Age: 
77(7)/78(6); Male: 
63/59; NYHA: 
2.99/2.89; Country: 
Australia 
Follow-up at a nurse-led heart 
failure clinic; given 
individualised education and 
psychosocial support, and 
protocol led medication 
changes.  
Conventional follow-up in 
primary health care. Some got 
scheduled visit after discharge, 
but most patients were 
encouraged to phone primary 
health care in case of problems.  
DSD, SMS 12 90 (RCT) 
Author, year of 
publication 
Population†             Intervention Control  Components 
(DSD, SMS, 
DS, CIS)†† 
FU 
(months) 
Quality 
(study 
design)††† 
Tsuyuki et al., 2004 N: 140/ 136; Age: 
72(12)/71(12); Male: 
58/58; NYHA: 
2.33/2.2; Country: 
Canada 
Two stage intervention: 1) a 
pharmacist nurse assessed each 
patient and made 
recommendations to the 
physician to adjust ACEs; 2) 
patient education about self-
management, adherence aids, 
newsletters, telephone hotline, 
and follow-up at 2 weeks, then 
monthly for 6 months after 
discharge. 
Received stage 1 of the 
intervention and followed by care 
as usual.  
SMS, CIS 6 45 (RCT) 
Vavouranakis et al., 
2003 
N: 28/ 33; Age: Total: 
65.4 (6.7); Male: 
Total: 88; NYHA: 
Total:3.39; Country: 
USA 
A home based intervention 
including education and follow-
up by nurses supervised by a 
cardiologist. 
The period without a home-based 
intervention. 
DSD, SMS, CIS 12 65 (BA) 
West et al., 1997 N: 45/ 50; Age: Total: 
66(10); Male: Total: 
71; NYHA: Total:2.3; 
Country: USA 
A physician supervised, nurse-
mediated, home-based system to 
promote optimal dose of drugs 
by consensus guidelines; 
promote of low sodium intak 
and surveillance of symptoms 
and worsening. 
Not described. DSD, SMS, DS, 
CIS 
6 55 (BA) 
Whellan et al., 2001 N: 117/ 117; Age: 
Total: 62; Male: 
Total:62; NYHA: 
Total:2.7; Country: 
USA 
CHF disease management 
program at a tertiary care centre 
including patient education and 
regular (telephone) follow-up.  
Care as usual.  DSD, SMS, DS, 
CIS 
12 60 (BA) 
† N (I/C); mean age (I/C); %-male (I/C); NYHA-class (I/C) and country.  
†† DSD, delivery system design; SMS, self management support, DS, decision support; CIS, clinical information system. 
††† RCT,randomized controlled trial; CCT, non-randomized controlled clinical trial; BA, before-after study.  
Table 2: Results meta-analysis and meta-regression  
 
 
 No. of 
studies 
No. of 
participants 
Relative risk  (95%-CI; I2) †            Explained heterogeneity 
(p-value)     
Hospitalisation 22 6586 0.82 (0.72-0.94; 84%) *  
Quality    1.7% (0.616) 
Poor 1 276 1.12 (0.84-1.50; NA)  
Moderate 8 1868 0.78 (0.53-1.14; 92%)  
Good 13 4442 0.86 (0.78-0.96; 61%) *  
Length of follow-up    3.1% (0.566) 
< 1 year 10 2590 0.81 (0.58-1.12; 91%)  
≥ 1 year 12 3996 0.85 (0.77-0.95; 60%)*  
Number of components    1% (0.789) 
2 3 361 1.02 (0.82-1.25; 0%)  
3 8 2186 0.69 (0.49-0.97; 94%)*  
4 11 4039 0.91 (0.83-1.01; 54%)  
 No. of 
studies 
No. of 
participants 
Relative risk (95%-CI; I2) †           Explained heterogeneity 
(p-value)     
Mortality  27 6832 0.82 (0.76-0.93; 0%)*  
Quality    No heterogeneity (0.915) 
Poor 3 474 0.69 (0.50-0.95;10%)*  
Moderate 8 1797 1.00 (0.78-1.28; 21%)  
Good 15 4327 0.79 (0.67-0.93; 30%)*  
Length of follow-up    No heterogeneity (0.781) 
< 1 year 11 2268 0.94 (0.74-1.18; 0%)  
≥ 1 year 16 4564 0.79 (0.68-0.91; 29%)*  
Number of components    No heterogeneity (0.191) 
2 5 692 0.67 (0.50-0.91; 8%)*  
3 10 2050 0.88 (0.69-1.13; 19%)  
4 12 4090 0.85 (0.73-0.98; 17%)*  
 No. of 
studies 
No. of 
participants 
Mean difference  (95%-CI; I2) †† Explained heterogeneity      
(p-value) 
Quality of life 7 992 -7.14  (-9.55--4.72; 78%)*  
Quality    NA 
Poor 0 NA NA  
Moderate 4 588 -6.65 (-14.19-0.88; 78%)  
Good 3 404 -10.93 (-16.96- -5.71; 50%)*  
Length of follow-up    NA 
< 1 year 5 692 -10.64 (-15.77- - 5.51; 78%)*  
≥ 1 year 2 300 -1.71 (-10.68-7.25; 63%)  
Number of components    NA 
2 1 72 -21.00 (-33.23 - -8.77; NA)*  
3 3 456 -9.19 (-14.67 - -3.70; 56%)*  
4 3 464 -4.32 (-14.46 - 5.82; 85%  
 
 
†
 Relative risk for CCM within the various subgroups; 
††
Mean difference for CCM within the 
various subgroups; CI, confidence interval; I
2
, statistical heterogeneity; *,p-value <0.05. 
 
 
 
